Avita Medical | Koszty Sprzedaży I Administracji



Selling And Administration Expenses Zmiana Data
Adcock Ingram Holdings ZAR 1.05B 50.17M 2024-12
Celltrion KRW 276.8B 58.09B 2025-03
Clinuvel Pharmaceuticals AUD 16.21M 3.62M 2024-06
Cochlear AUD 470M 4.4M 2024-12
CSL USD 1.18B 201M 2024-12
Cspc Pharmaceutical CNY 2.1B 22.82M 2024-09
Dianthus Therapeutics USD 6.83M 287K 2024-12
Divis Laboratories Ltd 3.41B 440M 2025-03
Kangmei Pharma CNY 245.26M 66.07M 2024-09
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 32.57M 26.69M 2024-06
Malin Corporation EUR 1.1M 400K 2024-12
Mayne Pharma AUD 54.8M 11.94M 2024-06
Medical Developments International AUD 12.94M 5.87M 2024-12
Nanosonics AUD 50.26M 26.17M 2024-12
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Organigram Holdings CAD 17.19M 2.88M 2024-12
Pacific Edge NZD 19.43M 12.04M 2024-09
Paradigm Biopharmaceuticals AUD 2.36M 639.57K 2024-12
Pharma Mar EUR 13.68M 450K 2025-03
Polynovo AUD 21.13M 18.27M 2024-06
PYC Therapeutics AUD 2.58M 1.57M 2024-12
Qiagen NV USD 137.94M 3.77M 2025-03
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 241.61M 2.63M 2024-12
Sartorius EUR 231.9M 13.6M 2025-03
Sino Biopharmaceutical CNY 5.31B 1.89B 2024-12
Telix Pharmaceuticals AUD 87.69M 29.72M 2024-06
Tilray USD 72.38M 4.99M 2024-11
Zz Pientze Pharmaceu 171.29M 130.03M 2025-03



Avita Medical Koszty Sprzedaży I Administracji - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jun 2025.